EDGAR Filing Documents for 0001615774-19-006339

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001615774-19-006339

Filing Date

2019-04-26

Accepted

2019-04-26 14:07:40

Documents

Period of Report

2017-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	s117409_10k.htm	10-K	1154684
2	EXHIBIT 3.08(I)	s117409_ex3-08i.htm	EX-3.08(I)	84132
3	EXHIBIT 4.45	s117409_ex4-45.htm	EX-4.45	9539
4	EXHIBIT 10.23	s117409_ex10-23.htm	EX-10.23	11679
5	EXHIBIT 14.01	s117409_ex14-01.htm	EX-14.01	10793
6	EXHIBIT 21.01	s117409_ex21-01.htm	EX-21.01	1417
7	EXHIBIT 23.01	s117409_ex23-01.htm	EX-23.01	2113
8	EXHIBIT 31.1	s117409_ex31-1.htm	EX-31.1	10428
9	EXHIBIT 31.2	s117409_ex31-2.htm	EX-31.2	10115
10	EXHIBIT 32.1	s117409_ex32-1.htm	EX-32.1	7036
11	EXHIBIT 32.2	s117409_ex32-2.htm	EX-32.2	7074
12	EXHIBIT 99.01	s117409_ex99-01.htm	EX-99.01	35346
13	EXHIBIT 99.02	s117409_ex99-02.htm	EX-99.02	20117
14	EXHIBIT 99.03	s117409_ex99-03.htm	EX-99.03	15440
	Complete submission text file	0001615774-19-006339.txt		6488183

Data Files

Seq	Description	Document	Type	Size
15	XBRL INSTANCE FILE	nspx-20171231.xml	EX-101.INS	1350732
16	XBRL SCHEMA FILE	nspx-20171231.xsd	EX-101.SCH	54775
17	XBRL CALCULATION FILE	nspx-20171231_cal.xml	EX-101.CAL	57048
18	XBRL DEFINITION FILE	nspx-20171231_def.xml	EX-101.DEF	259582
19	XBRL LABEL FILE	nspx-20171231_lab.xml	EX-101.LAB	422341
20	XBRL PRESENTATION FILE	nspx-20171231_pre.xml	EX-101.PRE	370660

Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258

Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112

Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)